Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;8(6):278.
doi: 10.1007/s13205-018-1282-3. Epub 2018 May 28.

l-Asparaginase: a feasible therapeutic molecule for multiple diseases

Affiliations

l-Asparaginase: a feasible therapeutic molecule for multiple diseases

Archana Vimal et al. 3 Biotech. 2018 Jun.

Abstract

This note highlights our understanding and thinking about the feasibility of l-asparaginase as therapeutics for multiple diseases. l-asparaginase enzyme (l-asparagine amidohydrolase, EC 3.5.1.1) is prominently known for its chemotherapeutic application. It is primarily used in the treatment of acute lymphoblastic leukemia in children. It is also used in the treatment of other forms of cancer Hodgkin disease, lymphosarcoma, acute myelomonocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, reticulosarcoma and melanosarcoma (Lopes et al. Crit Rev Biotechnol 23:1-18, 2015). It deaminates l-asparagine present in the plasma pool causing the demise of tumor cell due to nutritional starvation. The anti-tumorigenic property of this enzyme has been exploited for over four decades and evidenced as a boon for the cancer patients. Presently, the medical application of l-asparaginase is limited only in curing various forms of cancer.

Keywords: Autoimmune disease; Infectious disease; Malignance; Therapeutic; l-asparaginase.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standardsThe authors have declared no conflict of interest.

Figures

Fig. 1
Fig. 1
Application of l-asparaginase in the treatment of various diseases

References

    1. Baruch M, Belotserkovsky I, Hertzog BB, et al. An extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferation. Cell. 2014;156:97–108. doi: 10.1016/j.cell.2013.12.007. - DOI - PMC - PubMed
    1. Baruch M, Hertzog BB, Ravins M, et al. Induction of endoplasmic reticulum stress and unfolded protein response constitutes a pathogenic strategy of group A streptococcus. Front Cell Infect Microbiol. 2014;4:1–5. doi: 10.3389/fcimb.2014.00105. - DOI - PMC - PubMed
    1. Eckhardt M, Barth H, Blo D, Aktories K. Binding of clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates. J Biol Chem. 2000;275:2328–2334. doi: 10.1074/jbc.275.4.2328. - DOI - PubMed
    1. Gesbert G, Ramond E, Rigard M, et al. Asparagine assimilation is critical for intracellular replication and dissemination of Francisella. Cell Microbiol. 2014;16:434–449. doi: 10.1111/cmi.12227. - DOI - PubMed
    1. Gieldanowski J. Studies on the immunosuppressive and anti-inflammatory action of L-asparaginase. Arch Immunol Ther Exp (Warsz) 1976;24:243–247. - PubMed